openPR Logo
Press release

SMi's Paediatric Clinical Trials conference held on the 21st & 22nd March 2012, London

11-25-2011 06:50 AM CET | Health & Medicine

Press release from: SMi Group

SMi's Paediatric Clinical Trials conference held on the 21st &

Many drugs which are prescribed to children have not been adequately studied in the paediatric population. Pharmaceutical companies are now required to produce medicines specifically aimed at 0-17 year olds which has resulted in an increase in paediatric clinical trials. Trials in children are tightly regulated and have both operational and ethical challenges which need to be overcome.

Don’t miss out on this fantastic opportunity to network with experts in the field that includes:

Klaus Rose, Paediatric Drug Development Consultant, Klausrose Consulting
Lisa Moore-Ramdin, Senior Medical Advisor, Paediatric Vaccines, GlaxoSmithKline
Sabine Desset-Brethes, Project Leader, Pharmaceutical & Analytical Development, Novartis
Georg Schmitt, Head of Toxicology & NCS Paediatrics, F. Hoffman-La Roche
David McIntosh, Global Scientific Affairs Senior Expert, Novartis
Stephen Heaton, Head of Safety Risk Management Planning & Coordination, Bayer Healthcare
Thomas Hassall, Senior Director, Regulatory Policy & Intelligence, Abbott Laboratories
Ashley Strougo, Scientist, PK Modelling & Simulation, Astellas
Joseph Standing, Paediatric Clinical Lecturer, School of Pharmacy, University College London
Dirk Matthys, Head of Paediatrics, Ghent University Hospital
Hans Stoetter, Head of the Paediatric Working Group, Swissmedic

There will also be two interactive pre-conference workshops held on the 20th March, hosted by Gaynor Anders, Vice President/Head of Global Operations MMG and Klaus Rose – Managing Director Klausrose Consulting

For more information and to book your place visit http://www.smi-online.co.uk/paediatric-trials20.asp

Alternatively, contact Andrew Gibbons at Tel: +44 (0)20 7827 6156 or Email: agibbons@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group
30 Great Guildford Street
SE1 0HS

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi's Paediatric Clinical Trials conference held on the 21st & 22nd March 2012, London here

News-ID: 202004 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Paediatric

01-16-2025 | Health & Medicine
Getnews
Orchid Medical Centre: Providing Standard Paediatric Gastroenterology Services i …
Image: https://www.globalnewslines.com/uploads/2025/01/1737021836.jpg Orchid Medical Centre, a leading medical care service, provides reliable and competent gastroenterologists in Ranchi. When there is a medical service to always count on, families and individuals will feel safer and more in control of their health needs. Orchid Medical Centre is a reliable hospital that provides standard medical treatment services. The hospital has well-trained doctors on its team. With years of experience in the medical field, they serve
Paediatric Vaccine Market Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Paediatric Vaccine Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Paediatric Vaccine Market Breakdown by Application (Age(0-3), Age(3-12), AgeAbove12) by Type (Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis, MMR, PediatricHormones, HIB, AllergyandRespiratoryvaccines, OtherPediatricvaccines) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Paediatric Vaccine Market 2023 Report makes available the current and forthcoming technical
Paediatric Vaccine Market - Industry Trends and Forecast to 2029
The Global Paediatric Vaccine Market Growth at a rate of 9.80% in the forecast period 2022 to 2029. Global Paediatric Vaccine Market Size The paediatric vaccines are used to prevent children from contracting several infectious and non-infectious diseases. The prevalence of chronic diseases is escalating the growth of the paediatric vaccine market. Global paediatric vaccine market was valued at USD 35.74 billion in 2021 and is expected to reach USD 68.78 billion by
Paediatric Sports Medicine Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Paediatric Sports Medicine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html   Paediatric specialist treat the unique sports-related medical
Global Paediatric Perfusion Devices Market Trend and Forecast 2025
This report studies the global market size of Paediatric Perfusion Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paediatric Perfusion Devices in these regions. This research report categorizes the global Paediatric Perfusion Devices market by top players/brands, region, type and end user. This report also studies the global Paediatric Perfusion Devices market status, competition landscape,
Global Paediatric Respiratory Disease Therapeutics Market Research Report 2017
In this report, the global Paediatric Respiratory Disease Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Paediatric Respiratory Disease Therapeutics in these regions, from 2012